Tempus Small Cell Lung Cancer Observational Study (Sculptor)
NCT05257551
This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .
Summary
The study is a non-interventional evaluation of participants with extensive stage (ES) SCLC who will receive diagnostic and (where possible) post-progression tumor tissue profiling, alongside plasma ctDNA and CTC biomarker profiling during standard of care therapy in both first and second line treatment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Small Cell Lung Cancer
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Tempus AI
- Last updated on ClinicalTrials.gov
- June 15, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Colorado · 1
- University of Colorado · Aurora, CO
Illinois · 1
- Illinois Cancer Care · Peoria, IL
Maryland · 1
- Johns Hopkins University · Baltimore, MD
North Carolina · 1
- University of North Carolina · Chapel Hill, NC
Ohio · 2
- TriHealth Cancer Institute · Cincinnati, OH
- Ohio State University · Columbus, OH
Pennsylvania · 1
- Cancer Care Association of York · York, PA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.